SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-035275
Filing Date
2023-10-03
Accepted
2023-10-03 17:17:26
Documents
114
Period of Report
2022-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52671
2 ex23-1.htm EX-23.1 3727
3 ex99-1.htm   iXBRL EX-99.1 983526
4 ex99-2.htm EX-99.2 141318
  Complete submission text file 0001493152-23-035275.txt   8059602

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bfri-20221231.xsd EX-101.SCH 80176
6 XBRL CALCULATION FILE bfri-20221231_cal.xml EX-101.CAL 93548
7 XBRL DEFINITION FILE bfri-20221231_def.xml EX-101.DEF 349037
8 XBRL LABEL FILE bfri-20221231_lab.xml EX-101.LAB 568940
9 XBRL PRESENTATION FILE bfri-20221231_pre.xml EX-101.PRE 469430
106 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 1197797
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 231305397
SIC: 2834 Pharmaceutical Preparations